Melinda Liggett Irwin, PhD, MPH, associate professor of epidemiology (chronic diseases), Yale School of Public Health, co-program leader, Cancer Prevention and Control Research Program, Yale Cancer Center, discusses the impact of the LIVESTRONG at the YMCA Program on survivors' fitness, physical activity, and quality of life.

Yale Cancer Center and Dana-Farber Cancer Institute evaluated the efficacy of the LIVESTRONG Foundation’s free three-month exercise program offered to cancer survivors. The study showed that the program significantly improved physical activity levels, cardiorespiratory fitness, quality of life, and cancer-related fatigue.

Data from observational studies demonstrate that physical activity done before and after a cancer diagnosis is associated with improvements in prognosis, recurrence, and mortality. Results from randomized controlled trials have shown that exercise improves biological markers, such as inflammatory or metabolic markers measured in the blood.

Videos

Melinda Irwin on Impact of Exercise on Survivors' Quality of Life

Melinda L. Irwin, PhD, MPH, associate professor, Yale School of Public Health, co-program leader, Cancer Prevention and Control Research Program, Yale Cancer Center, discusses the results of studies she conducted examining the effects of exercise and weight loss in patients with breast cancer.

It is believed that exercise and weight are related to developing certain types of cancer, such as breast cancer, Irwin explains. However, an observational finding that exercise after diagnosis of breast cancer could lower the risk of recurrence or mortality led Irwin to conduct studies of the biological mechanisms that could explain this association.

One of the studies looked at women with breast cancer who did not exercise, and randomized them to begin an exercise program or usual care. Researchers collected blood, and found that exercise was linked to decreases in blood-based biomarkers such as insulin and c-reactive protein (CRP), which are associated with developing and dying from breast cancer.

Irwin also examined weight loss with exercise in patients already diagnosed with breast cancer. The study demonstrated similar findings, such as a 30% decrease in CRP from an approximate 5% weight loss in women with breast cancer.

Melinda L. Irwin, PhD, MPH, associate professor, Yale School of Public Health, co-program leader, Cancer Prevention and Control Research Program, Yale Cancer Center, discusses the results of a study she conducted examining the effects of exercise and weight loss in patients with breast cancer.

Melinda L. Irwin, PhD

Articles

Melinda Irwin on Impact of Exercise on Survivors' Quality of Life

Dr. Irwin on Exercise and Weight Loss After Breast Cancer Diagnosis